{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:12:23Z","timestamp":1777349543742,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ajkd.2001.27428","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T23:33:20Z","timestamp":1205796800000},"page":"S161-S164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"S","title":["Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy"],"prefix":"10.1053","volume":"38","author":[{"given":"Takehisa","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soji","family":"Kasayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2001.27428_BIB1","first-page":"347","article-title":"Renal osteodystrophy in adults and children","author":"Goodman","year":"1996"},{"key":"10.1053\/ajkd.2001.27428_BIB2","doi-asserted-by":"crossref","first-page":"F1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2001.27428_BIB3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation endproducts in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2001.27428_BIB4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI117002","article-title":"Involvement of \u03b22-microglobulin modified with advanced glycosylation endproducts in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor-necrosis factor and interleukin-1","volume":"93","author":"Miyata","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2001.27428_BIB5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1359\/jbmr.1997.12.3.439","article-title":"Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells","volume":"12","author":"Takagi","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1053\/ajkd.2001.27428_BIB6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jbmr.5650060109","article-title":"In vivo osteogenic activity of isolated human bone cells","volume":"6","author":"Yamamoto","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1053\/ajkd.2001.27428_BIB7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jbmr.5650061002","article-title":"Perspective: The genomic mechanism of action of 1,25-dihydroxyvitamin D3G","volume":"6","author":"Ozono","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1053\/ajkd.2001.27428_BIB8","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1074\/jbc.275.5.3335","article-title":"Parathyroid hormone-activated volume-sensitive calcium influx pathways in mechanically loaded osteocytes","volume":"275","author":"Miyauchi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/ajkd.2001.27428_BIB9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.1984.73","article-title":"Parathyroid and bone response of the diabetic patients to uremia","volume":"25","author":"Vincenti","year":"1984","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27428_BIB10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/jbmr.5650100709","article-title":"Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells","volume":"10","author":"Inaba","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1053\/ajkd.2001.27428_BIB11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jbmr.5650110709","article-title":"Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia","volume":"11","author":"Katayama","year":"1996","journal-title":"J Bone Miner Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601984975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601984975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:23:18Z","timestamp":1759454598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638601984975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0272638601984975"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2001.27428","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2001.27428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}